Bottom line
PBMIX vs CSMD: the short answer
PBMIX (Polen U.S. SMID Company Growth Fund) and CSMD (Congress SMid Growth ETF) are both mutual funds.
CSMD is cheaper at 0.68% vs 1.05% — a difference of $37 a year per $10,000 invested.
Over one year, CSMD returned +5.7% vs +1.5% for PBMIX (reporting dates differ).
Updated Nov 19, 2026
PBMIX vs CSMD side by side
| PBMIX | CSMD | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fundvantage | Tortoise |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 1.05% | 0.68% |
| Annual cost per $10k | $105 | $68 |
| 10-yr cost on $10k (prospectus) | $2,343 | $847 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +1.5% | +5.7% |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +14.7% | +12.5% |
| Worst quarter | −29.5% | −7.3% |
| Net assets (fund) | — | $454.1M |
| Number of holdings | — | 47 |
| Portfolio turnover | 58% | 23% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PBMIX | CSMD | Difference |
|---|---|---|---|
| 2024 | +1.5% | +12.1% | −10.6% |
Source: Fund prospectus bar charts
Holdings overlap
PBMIX and CSMD share none of their top holdings.
PBMIX top 10
CSMD top 10
- Curtiss-Wright Corp — 4.23%
- nVent Electric PLC — 3.62%
- Carpenter Technology Corp — 3.49%
- Valmont Industries Inc — 3.47%
- Rubrik Inc — 3.35%
- Halozyme Therapeutics Inc — 2.87%
- BJ's Wholesale Club Holdings I — 2.80%
- Repligen Corp — 2.78%
- Medpace Holdings Inc — 2.78%
- Rambus Inc — 2.72%
FAQ
What is the difference between PBMIX and CSMD?
PBMIX (Polen U.S. SMID Company Growth Fund) and CSMD (Congress SMid Growth ETF) are both mutual funds. CSMD is cheaper at 0.68% vs 1.05% — a difference of $37 a year per $10,000 invested.
Which is cheaper, PBMIX or CSMD?
CSMD has the lower expense ratio (0.68%).
Should I own both PBMIX and CSMD?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.